CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company
Damora Therapeutics, Inc.
Sign in to watch- Ticker
- DMRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371957007
- Phone
- (781) 281-9020
- Business address
- 100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
- Former names
- Galecto, Inc., Galecto Inc.
- 4 Open-market buy Director, President and CEO bought 12,500 shares at $20.23 ($252,875)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale General Counsel sold 245 shares at $29.98 ($7,345)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award See Remarks acquired 500,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 129,000 shares (option exercise)
- 4 Option exercise Director acquired 8,713,000 shares (option exercise)
- 4 Grant or award Chief Operating Officer acquired 190,376 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Medical Officer acquired 264,629 shares (grant or award)
Page 1 of 7 · 135 filings